MedTrace Logo

Exercise for Preventing the Metabolic Syndrome in Latinoamerican Amerindians

NCT03653468 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2018-08-31

No results posted yet for this study

Summary

Despite exercise training decrease blood fasting glicaemy in 'average' terms, there is a wide inter-individual variability after exercise training explored mainly in adults but not in adults with prediabetes comorbidities. Thus, is yet unknown the effects and influence of the concurrent training (CT) eliciting responders (R) and non-responders (NR) cases (i.e., percentage of subjects who experienced a non-change/worsened response after training in some metabolic outcomes).

Conditions

  • Obesity
  • Cardiovascular Risk Factor
  • Physical Activity

Interventions

BEHAVIORAL

Concurrent training (CT)

The core part of each session included resistance training (RT) followed by aerobic training exercises (for 50 and 30 minutes, respectively) and was preceded and followed by a 5-minute warm-up and cool-down with callisthenic movements.

Sponsors & Collaborators

  • Universidad del Rosario

    collaborator OTHER

  • Universidad Pública de Navarra

    collaborator OTHER

  • Healthcare Center Tomas Rojas

    collaborator OTHER

  • Universidad de Los Lagos

    collaborator OTHER

  • Universidad Santo Tomas

    lead OTHER

Principal Investigators

  • Cristian Alvarez, PhD · Universidad de Los Lagos

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
59 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-05-28
Completion
2018-08-25

Countries

  • Chile

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03653468 on ClinicalTrials.gov